相关实验视频
Updated: May 22, 2025

10:55
Purification of Ubiquitinated p53 Proteins from Mammalian Cells
Published on: March 21, 2022
2.0K
PP2A适配蛋白IER5诱导MDM2的脱化和降解,从而稳定了p53
Taisei Nakada1, Mayuko Koga1, Hiroto Takeuchi1
1Division of Health Sciences, Graduate School of Medical Science, Kanazawa University, 5-11-80 Kodatsuno, Kanazawa, Ishikawa 920-0942, Japan.
Cellular signalling
|March 13, 2025
概括
适配蛋白IER5通过抑制瘤抑制剂p53 (蛋白53) 的无处不在,从而稳定瘤抑制剂p53. 这种调节涉及蛋白质酸酶PP2A/B55复合物和MDM2结合酶,维持核p53水平.
科学领域:
- 分子生物学分子生物学
- 蜂信号传输是如何进行的
- 癌症研究 癌症研究
背景情况:
- 瘤抑制剂p53在细胞对压力的反应中起着至关重要的作用.
- 通过全方位化 (ubiquitination) 严格调节p53水平,主要通过MDM2 (鼠标双分钟2同类物) 调节.
- IER5 (即时早期反应5) 是一个由p53激活的基因,编码为蛋白质酸酶PP2A的适配蛋白.
研究的目的:
- 研究IER5在调节p53稳定性和功能的作用.
- 阐明IER5影响p53无处不在的机制.
- 了解p53规则中的IER5,PP2A/B55和MDM2之间的相互作用.
主要方法:
- 西方涂抹以评估蛋白质水平和无处不在.
- 免疫沉以研究蛋白质与蛋白质相互作用.
- 细胞局部化研究 (核/细胞质分离).
- 用MDM2抑制剂Nutlin-3进行治疗.
主要成果:
- IER5抑制了p53的无处不在,导致细胞p53水平增加.
- IER5需要核定位和结合PP2A/B55和MDM2来实现这个功能.
- IER5-PP2A/B55复杂脱酸盐 MDM2 在Ser166.6.
- 通过IER5-PP2A/B55对MDM2的脱化导致MDM2的无处不在和核MDM2水平的降低.
- IER5对p53无处不在的抑制取决于MDM2的活性.
结论:
- IER5通过防止其无处不在的作用,作为p53的积极调节者.
- IER5-PP2A/B55复合物通过MDM2.2的脱化来调节p53的稳定性.
- 这种机制调节MDM2和p53之间的核平衡,影响瘤抑制.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Negative Regulator Molecules
35.1K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.1K
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K

